These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

480 related articles for article (PubMed ID: 26015481)

  • 1. Four-component Staphylococcus aureus vaccine 4C-staph enhances Fcγ receptor expression in neutrophils and monocytes and mitigates S. aureus infection in neutropenic mice.
    Torre A; Bacconi M; Sammicheli C; Galletti B; Laera D; Fontana MR; Grandi G; De Gregorio E; Bagnoli F; Nuti S; Bertholet S; Bensi G
    Infect Immun; 2015 Aug; 83(8):3157-63. PubMed ID: 26015481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. One Dose of Staphylococcus aureus 4C-Staph Vaccine Formulated with a Novel TLR7-Dependent Adjuvant Rapidly Protects Mice through Antibodies, Effector CD4+ T Cells, and IL-17A.
    Mancini F; Monaci E; Lofano G; Torre A; Bacconi M; Tavarini S; Sammicheli C; Arcidiacono L; Galletti B; Laera D; Pallaoro M; Tuscano G; Fontana MR; Bensi G; Grandi G; Rossi-Paccani S; Nuti S; Rappuoli R; De Gregorio E; Bagnoli F; Soldaini E; Bertholet S
    PLoS One; 2016; 11(1):e0147767. PubMed ID: 26812180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MF59- and Al(OH)3-Adjuvanted Staphylococcus aureus (4C-Staph) Vaccines Induce Sustained Protective Humoral and Cellular Immune Responses, with a Critical Role for Effector CD4 T Cells at Low Antibody Titers.
    Monaci E; Mancini F; Lofano G; Bacconi M; Tavarini S; Sammicheli C; Arcidiacono L; Giraldi M; Galletti B; Rossi Paccani S; Torre A; Fontana MR; Grandi G; de Gregorio E; Bensi G; Chiarot E; Nuti S; Bagnoli F; Soldaini E; Bertholet S
    Front Immunol; 2015; 6():439. PubMed ID: 26441955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A D-Alanine auxotrophic live vaccine is effective against lethal infection caused by Staphylococcus aureus.
    Moscoso M; García P; Cabral MP; Rumbo C; Bou G
    Virulence; 2018 Jan; 9(1):604-620. PubMed ID: 29297750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Individual variation is the key to the development of a vaccine against Staphylococcus aureus: a comparative study between mice lineages.
    Dos Santos DP; Muniz IPR; Queiroz AF; Pereira IS; Souza MPA; Lima LJ; Sousa LRO; Ribeiro IS; Galantini MPL; Marques LM; Figueiredo TB; da Silva RAA
    Braz J Med Biol Res; 2018 Mar; 51(5):e6773. PubMed ID: 29590259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of genetically inactivated alpha toxin for protection in multiple mouse models of Staphylococcus aureus infection.
    Brady RA; Mocca CP; Prabhakara R; Plaut RD; Shirtliff ME; Merkel TJ; Burns DL
    PLoS One; 2013; 8(4):e63040. PubMed ID: 23658662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune response of heifers against a Staphylococcus aureus CP5 whole cell vaccine formulated with ISCOMATRIX™ adjuvant.
    Camussone CM; Veaute CM; Porporatto C; Morein B; Marcipar IS; Calvinho LF
    J Dairy Res; 2013 Feb; 80(1):72-80. PubMed ID: 23171590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clearance of Staphylococcus aureus from
    Harro JM; Achermann Y; Freiberg JA; Allison DL; Brao KJ; Marinos DP; Sanjari S; Leid JG; Shirtliff ME
    Infect Immun; 2019 Dec; 88(1):. PubMed ID: 31712267
    [No Abstract]   [Full Text] [Related]  

  • 9. Preclinical Efficacy of Clumping Factor A in Prevention of Staphylococcus aureus Infection.
    Li X; Wang X; Thompson CD; Park S; Park WB; Lee JC
    mBio; 2016 Feb; 7(1):e02232-15. PubMed ID: 26838725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Harnessing antifungal immunity in pursuit of a Staphylococcus aureus vaccine strategy.
    Paterson MJ; Caldera JR; Nguyen C; Sharma P; Castro AM; Kolar SL; Tsai CM; Limon JJ; Becker CA; Martins GA; Liu GY; Underhill DM
    PLoS Pathog; 2020 Aug; 16(8):e1008733. PubMed ID: 32817694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune response and functional role of antibodies raised in heifers against a Staphylococcus aureus CP5 lysate and recombinant antigens vaccine formulated with Iscom Matrix adjuvant.
    Camussone CM; Pujato N; Renna MS; Veaute CM; Morein B; Marcipar IS; Calvinho LF
    Vet Immunol Immunopathol; 2014 Dec; 162(3-4):96-107. PubMed ID: 25454469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting surface protein SasX by active and passive vaccination to reduce Staphylococcus aureus colonization and infection.
    Liu Q; Du X; Hong X; Li T; Zheng B; He L; Wang Y; Otto M; Li M
    Infect Immun; 2015 May; 83(5):2168-74. PubMed ID: 25776748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protection against Staphylococcus aureus Colonization and Infection by B- and T-Cell-Mediated Mechanisms.
    Zhang F; Ledue O; Jun M; Goulart C; Malley R; Lu YJ
    mBio; 2018 Oct; 9(5):. PubMed ID: 30327437
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunization with Staphylococcus aureus clumping factor B, a major determinant in nasal carriage, reduces nasal colonization in a murine model.
    Schaffer AC; Solinga RM; Cocchiaro J; Portoles M; Kiser KB; Risley A; Randall SM; Valtulina V; Speziale P; Walsh E; Foster T; Lee JC
    Infect Immun; 2006 Apr; 74(4):2145-53. PubMed ID: 16552044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective efficacy of the chimeric Staphylococcus aureus vaccine candidate IC in sepsis and pneumonia models.
    Yang L; Cai C; Feng Q; Shi Y; Zuo Q; Yang H; Jing H; Wei C; Zhuang Y; Zou Q; Zeng H
    Sci Rep; 2016 Feb; 6():20929. PubMed ID: 26865417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant ESAT-6-like proteins provoke protective immune responses against invasive Staphylococcus aureus disease in a murine model.
    Zhang BZ; Hua YH; Yu B; Lau CC; Cai JP; Zheng SY; Yam WC; Kao RY; Sze KH; Zheng BJ; Yuen KY; Huang JD
    Infect Immun; 2015 Jan; 83(1):339-45. PubMed ID: 25368117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective immunization against Staphylococcus aureus infection in a novel experimental wound model in mice.
    Schennings T; Farnebo F; Szekely L; Flock JI
    APMIS; 2012 Oct; 120(10):786-93. PubMed ID: 22958286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional role of antibodies generated in heifers through immunization with Staphylococcus aureus vaccines in invasion and phagocytosis assays.
    Renna MS; Pereyra EA; Baravalle C; Camussone CM; Dallard BE; Marcipar IS; Calvinho LF
    FEMS Microbiol Lett; 2014 Nov; 360(1):62-9. PubMed ID: 25155690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. c-di-GMP as a vaccine adjuvant enhances protection against systemic methicillin-resistant Staphylococcus aureus (MRSA) infection.
    Hu DL; Narita K; Hyodo M; Hayakawa Y; Nakane A; Karaolis DK
    Vaccine; 2009 Jul; 27(35):4867-73. PubMed ID: 19406185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunization with heat-inactivated Staphylococcus aureus induced an antibody response mediated by IgG1 and IgG2 in patients with recurrent tonsillitis.
    Garcia-Romo GS; Gonzalez-Ibarra M; Donis-Hernandez FR; Zendejas-Buitron VM; Pedroza-Gonzalez A
    Microbiol Immunol; 2015 Apr; 59(4):193-201. PubMed ID: 25648612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.